Qure AI

Founded in 2016, Qure.ai develops AI-powered medical imaging solutions that help clinicians detect diseases earlier and improve diagnosis workflows. Its product portfolio includes qXR for chest X-rays, qER for emergency head CT scans, qCT for lung cancer detection and follow-up, qMSK for musculoskeletal imaging, and AIRA, an AI clinical co-pilot for healthcare teams.

The company’s solutions support screening and management of tuberculosis, lung cancer, stroke, traumatic brain injuries, fractures, and other critical conditions, making radiology faster and more accessible, especially in regions with limited specialist availability.

Qure.ai has become one of the world’s most widely deployed healthcare AI companies, with its technology used across 5,500+ healthcare sites in more than 105 countries and impacting 45+ million lives. The company has trained its AI models on over one billion medical imaging datasets and has earned multiple global regulatory approvals, including FDA clearances, CE MDR certifications, and WHO evaluation for tuberculosis screening.